🇫🇷
France · FR · FR:63020895
MIDAZOLAM AGUETTANT 5 mg/ml, solution injectable
ReimbursedATC N05CD08
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerAGUETTANT
CountryFR (France)
ATC codeN05CD08
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 5
- cip13340093023309210 ampoule(s) en verre de 1 mlEUR 15.76
- cip13340093023315310 ampoule(s) en verre de 10 mlEUR 32.55
- cip13340095648734910 ampoule(s) en verre de 1 ml (abrogée le 18/12/2021 (notification du 21/07/2021))
- cip13340095648740050 ampoule(s) en verre de 1 ml (abrogée le 18/12/2021 (notification du 21/07/2021))
- cip13340095648786810 ampoule(s) en verre de 10 ml (abrogée le 18/12/2021 (notification du 21/07/2021))
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "63020895",
"date_amm": "2003-06-11",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable pour perfusion ou",
"voies_administration": "intramusculaire;intraveineuse;rectale;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code N05CD08.
- DKBuccolamNeuraxpharm Pharmaceuticals S.L.
- DKBuccolamNeuraxpharm Pharmaceuticals S.L.
- ISBuccolamNeuraxpharm Pharmaceuticals S.L.
- ISBuccolamNeuraxpharm Pharmaceuticals S.L.
- ISBuccolamNeuraxpharm Pharmaceuticals S.L.
- DKBuccolamNeuraxpharm Pharmaceuticals S.L.
- ISBuccolamNeuraxpharm Pharmaceuticals S.L.
- DKBuccolamNeuraxpharm Pharmaceuticals S.L.
Access this data programmatically
Query MIDAZOLAM AGUETTANT 5 mg/ml, solution injectable and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.